CompuGroup Medical AG

EANS-Adhoc: CompuGroup Medical AG
The Management Board decides share buyback

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.

The Management Board of CompuGroup Medical AG, Koblenz, ISIN DE0005437305 (the
company), in accordance with Section 71 (1) 8 of the German Stock Corporation
Act (Aktiengesetz), decided on December 19, 2011 to make use of the
authorization to buy back shares of the company granted by the shareholders at
the annual general meeting on May 19, 2010.
Up to 500,000 shares of the company will be repurchased, corresponding to
approximately 0.94 percent of the company's share capital.
The repurchased shares can be used for all purposes covered by the
authorization of the annual general meeting.
Shares will be repurchased exclusively through the XETRA trade of Deutsche
Börse AG (Frankfurt Stock Exchange). The share buyback will be conducted in
compliance with the terms of trade detailed in Article 5 of Commission
Regulation (EC) No. 2273/2003 of December 22, 2003.

The price the company pays per share is not allowed to exceed ten per cent more
or less than the stock market price. The authoritative stock market price in
this context is the non-weighted average price of the company´s share which is
determined by the closing auction in XETRA trading at Frankfurt Stock Exchange
on the last five stock exchange trading days before the day when the shares are
acquired. In addition to this, the shares will not be acquired at prices that
are above the last independently made sale or, if it is higher, the last
independent offer to buy the shares in XETRA trading at Frankfurt Stock

The share buyback will be executed by a credit institute which will decide on
the time of the share's purchase independently and uninfluenced by the company.

The share buyback will commence, after the current buy back has lapsed on
December 31, 2011, from January 2, 2012 and will end June 30, 2012 at the
latest. The company's Management Board can decide to terminate the share
buyback early at any time.

Further inquiry note:
Ralf Glass
Vicepresident CEO support
T +49 (0) 160 3630315

end of announcement                               euro adhoc 

issuer:      CompuGroup Medical AG
             Maria Trost 21
             D-56070 Koblenz
phone:       +49 (0) 261 8000-0
FAX:         +49 (0) 261 8000-1166
sector:      Software
ISIN:        DE0005437305
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Hamburg, Stuttgart, Düsseldorf, München 
language:   English

Weitere Meldungen: CompuGroup Medical AG

Das könnte Sie auch interessieren: